Purpose: Explosive performance is increased right after performing loaded resistance exercise, which is known as post-activation performance enhancement (PAPE). Method: We investigated the effects of a plyometric exercise (PLYO) consisting of five sets of six drop-jumps from a 52-cm platform with a load corresponding to 20% body mass on changes in countermovement jump (CMJ) height in sedentary young men. Eleven young nonresistance trained men (19.6 ± 1.8 y, 69 ± 9 kg, 1.76 ± 0.08 m) who showed more than 4% increase in CMJ height at 4 min after five back squats with five-repetition maximum load participated in the study. Their responses to the back squat exercise were examined before (baseline) and 15 minutes, 24 and 48 hours post-PLYO. Exercise-induced muscle damage markers (maximal voluntary contraction torque [MVC], and quadriceps muscle soreness) were assessed at baseline, 15 minutes, 24 and 48 hours following PLYO. Results: MVC torque decreased (p < .05) at 15 minutes post-PLYO (−15.1 ± 9.7%) but returned to the baseline at 24 hours post-PLYO. Muscle soreness developed (p < .05) at 48 hours (21.0 ± 20.3 mm) after PLYO, indicating minor muscle damage. CMJ height increased (p < .05) after the five squats at baseline (7.6 ± 3.8%) indicating PAPE, but no such increase was found at 15 minutes, 24 and 48 hours after PLYO. However, CMJ height before the squat exercise was greater (p < .05) at 24 (5.9 ± 7.0%) and 48 hours post-PLYO (9.1 ± 8.5%) than the baseline. Conclusions: These results showed that PAPE disappeared after PLYO that induced minor muscle damage, but CMJ height increased at 24–48 hours in the recovery from PLYO exhibiting a priming effect.
1 January 2021 in Revista Brasileira de Cineantropometria & Desempenho Humano
We aimed to investigate the influence of alpha-actinin-3 (ACTN3) R577X polymorphism on responsiveness to post-activation performance enhancement (PAPE) of countermovement jumps (CMJ) in untrained subjects. Sixteen untrained men were allocated into two groups according to their ACTN3 gene alleles: homozygous for the X allele (XX, n = 9) or homozygous for the R allele (RR, n = 7). CMJ height, mean power output and vertical force were determined twice (CMJ1 and CMJ2) in two conditions: control (CON) and potentiated (PAPE). In the CON condition, CMJ were performed before and after a 15-min rest. In the PAPE condition, CMJ were performed 15 min before and 4 min following five squats with a 5-repetition maximum (5RM) load. Different conditions were applied on separate days in a randomized order. Statistical analysis involved three-way ANOVAs to compare the differences between conditions (CON and PAPE), time (CMJ1 and CMJ2), and groups (XX and RR). Significance level considered was p < 0.05. Effect sizes were calculated as Cohen’s d. The effect sizes for changes in CMJ height for CON and following pre-activation for PAPE were 0.04 and 0.08, respectively. No significant differences were found for CMJ height between XX and RR at baseline (1.07 ± 2.54 cm e -0.82 ± 2.56 cm, respectively). No differences were found (p>0.05) in responsiveness to PAPE between the groups (XX = -0.20 ± 1.6 cm and RR = -0.81 ± 2.7 cm). We conclude that ACTN3 gene polymorphisms does not influence responsiveness to PAPE.